| --- | --- | |--------------------|-----------------------------------------------------------------------------------| | | | | | | | | | | | Immunic Therapeutics Developing Selective Oral Drugs in Immunology NASDAQ: IMUX | | Ladenburg Thalmann | Healthcare Conference September 24, 2019 | Cautionary Note Regarding Forward-Looking Statements • Certain statements contained in this presentation regarding matters that are not historical facts are forward-looking statements within the meaning of Section 21E of ...